| pubmed-article:21030383 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21030383 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:21030383 | lifeskim:mentions | umls-concept:C0024554 | lld:lifeskim |
| pubmed-article:21030383 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:21030383 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:21030383 | lifeskim:mentions | umls-concept:C0035363 | lld:lifeskim |
| pubmed-article:21030383 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
| pubmed-article:21030383 | lifeskim:mentions | umls-concept:C1710133 | lld:lifeskim |
| pubmed-article:21030383 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21030383 | pubmed:dateCreated | 2011-4-27 | lld:pubmed |
| pubmed-article:21030383 | pubmed:abstractText | The outcome of germ-cell tumors (GCTs) is a hallmark of good-quality cancer care. In the Eurocare-4 study, the mean 5-year survival for patients diagnosed from 1995 to 1999 was 95.5%. | lld:pubmed |
| pubmed-article:21030383 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21030383 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21030383 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21030383 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21030383 | pubmed:month | May | lld:pubmed |
| pubmed-article:21030383 | pubmed:issn | 1569-8041 | lld:pubmed |
| pubmed-article:21030383 | pubmed:author | pubmed-author:SantosEE | lld:pubmed |
| pubmed-article:21030383 | pubmed:author | pubmed-author:BritzII | lld:pubmed |
| pubmed-article:21030383 | pubmed:author | pubmed-author:Passos-Coelho... | lld:pubmed |
| pubmed-article:21030383 | pubmed:author | pubmed-author:MirandaA CAC | lld:pubmed |
| pubmed-article:21030383 | pubmed:author | pubmed-author:Castro... | lld:pubmed |
| pubmed-article:21030383 | pubmed:author | pubmed-author:Sousa... | lld:pubmed |
| pubmed-article:21030383 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21030383 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:21030383 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21030383 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21030383 | pubmed:pagination | 1215-20 | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:meshHeading | pubmed-meshheading:21030383... | lld:pubmed |
| pubmed-article:21030383 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21030383 | pubmed:articleTitle | Suboptimal survival of male germ-cell tumors in southern Portugal--a population-based retrospective study for cases diagnosed in 1999 and 2000. | lld:pubmed |
| pubmed-article:21030383 | pubmed:affiliation | Medical Oncology Service, Instituto Portugues de Oncologia, Lisboa, Portugal. passoscoelho@sapo.pt | lld:pubmed |
| pubmed-article:21030383 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21030383 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
